Synthetic macrocyclic ketone microtubule disruptor administered via IV in metastatic breast cancer management. Utilized by medical oncologists in outpatient oncology clinics and hospital settings. Suppliers offer through pharmaceutical networks to healthcare buyers for chemotherapy supply chains.